Article Text
Rare disease
Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies
In this rare case, the patient presented with opsoclonus, myoclonus and ataxia. Serological and imaging studies revealed high glutamic acid decarboxylase antibody (GAD-Ab) levels. High-dose corticosteroids were of no benefit and subsequent intravenous immunoglobulin (IVIg) administration proved resolution of the condition. Levetiracetam proved useful in symptomatically controlling the myoclonus. Follow-up GAD-Ab levels were within normal limits.
Statistics from Altmetric.com
Footnotes
Competing interests None.
Patient consent Obtained.